The guidelines on the use of aspirin by the American College of Cardiology (ACC) and the American Heart Association (AHA) were altered in their latest release following the discovery of multiple studies.
Aspirin is recommended by physicians for adults to reduce their risk of developing cardiovascular (heart) diseases. Multiple studies on the consumption of aspirin revealed that taking this drug may result in complications like internal bleeding. This is considered to outweigh the benefits of using it in the first place.
“Low-dose aspirin ‘should rarely be used’ to prevent heart attacks and stroke in people over 70 or without known cardiovascular disease,” the new guideline stated.
Lots of American Adults Are at Risk
A lot of adults still take the pill in the hope of preventing heart complications. Reports show that they are unaware of the newly released guidelines by the ACC and AHA.
A new study conducted by the researchers at the Beth Israel Deaconess Medical Center examined 14,000 adults. Their findings were published in the Annals of Internal Medicine.
“Aspirin use in the United States is widespread among groups at risk.”
“For years, even adults without cardiovascular disease were told to take a daily low-dose of aspirin [typically 81 mg, whereas a regular dose is usually 325 mg]”, the report noted.
U.S. adults aged 40 and above are taking aspirin daily to prevent cardiovascular disease, according to the report. About 6.6 million of these adults were also discovered to have been taking it without the consent of their doctor.
Close to half of the adults ― approximately 10 million ― who are 70 years or older among the participants also take a low-dose aspirin every day even though they were never diagnosed with cardiovascular disease.
The Research Does Not Condemn Using Aspirin
The research report does in no way condemn the use of aspirin, instead, it discourages the administration in people without any symptoms of cardiovascular disease.
Aspirin effectiveness in alleviating heart-related diseases is not disputed, but the researchers are more concerned about the side effects of the usage and therefore do not think it worthwhile for use by people with no heart disease symptoms.
“If you’ve already had a heart attack or a stroke or a bypass procedure, have a stent or have been diagnosed with cardiovascular disease, and your doctor says you should take daily low-dose aspirin, continue to do so.” The AHA recommended.
The ACC, however, warns of the usage of the drug by people with health conditions like GI bleeding or peptic ulcer disease, and those with thrombocytopenia, coagulopathy, chronic kidney disease, among others. The Association also advised people who currently taking it and also present any of these complications to contact their doctor before discontinuing the use of the drug.
Following the publication of the research, the world-renown aspirin manufacturing company, Bayer (stock listed, BAYRY) experienced a fall in their shares by 0.79%.
In response to the research report, the company announced that the daily use of aspirin is “still recommended for millions of Americans who have had a heart attack or ischemic stroke”
“Aspirin is not appropriate for everyone, so patients should talk to their doctor before they begin an aspirin regimen.”
At the time of filing this news report, other main manufacturers of aspirin ― Bufferin and Ecotrin ― are yet to respond to all requests for their comments.